This Fortnight in Medicine XXVII

This Fortnight in Medicine XXVII

From Sensible Medicine by Sensible Medicine Authors and Editors

June 3, 2026 · 33 min

About this episode

The episode discusses recent findings on melanoma reduction from sunscreen use and the implications of GLP-1 receptor agonists and SGLT2 inhibitors on various health conditions.

Reduced Melanoma After Regular Sunscreen Use: Randomized Trial Follow-Up GLP-1 Receptor Agonists or SGLT2 Inhibitors and Nonarteritic Anterior Ischemic Optic Neuropathy * Previously discussed on Fornight XXII: Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: cohort study This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.sensible-med.com/subscribe

Topics covered

  • sunscreen use
  • melanoma
  • GLP-1 receptor agonists
  • SGLT2 inhibitors
  • nonarteritic anterior ischemic optic neuropathy
  • substance use disorders
  • type 2 diabetes

Keywords

  • melanoma
  • sunscreen
  • GLP-1
  • SGLT2
  • optic neuropathy
  • substance use
  • diabetes

Mentioned in this episode

Organizations: GLP-1 Receptor Agonists, SGLT2 Inhibitors, Nonarteritic Anterior Ischemic Optic Neuropathy, Fornight XXII, US veterans, type 2 diabetes

More episodes of Sensible Medicine

Explore listener stats, chart rankings, contacts and more on the Sensible Medicine podcast page.